Retractable Technologies

Retractable Technologies, Inc. is the manufacturer of VanishPoint® and Patient Safe® safety products. VanishPoint® products retract the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination.

Type
Public
HQ
Little Elm, US
Founded
1989
Size (employees)
134 (est)
Retractable Technologies was founded in 1989 and is headquartered in Little Elm, US

Retractable Technologies Office Locations

Retractable Technologies has an office in Little Elm
Little Elm, US (HQ)
511 Lobo Ln

Retractable Technologies Data and Metrics

Retractable Technologies Financial Metrics

Retractable Technologies's revenue was reported to be $29.8 m in FY, 2016 which is a 1% increase from the previous period.
USD

Revenue (FY, 2016)

29.8 m

Revenue growth (FY, 2015 - FY, 2016), %

1%

Gross profit (FY, 2016)

10.3 m

Gross profit margin (FY, 2016), %

35%

Net income (FY, 2016)

(3.7 m)

EBIT (FY, 2016)

(3.5 m)

Market capitalization (19-Jul-2017)

37.4 m

Closing share price (19-Jul-2017)

1.1

Cash (31-Dec-2016)

16.2 m

EV

21.6 m
Retractable Technologies's current market capitalization is $37.4 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

30.8 m34.5 m29.6 m29.8 m

Revenue growth, %

12%(14%)1%

Cost of goods sold

20.5 m22.5 m19 m19.5 m

Gross profit

10.3 m12 m10.6 m10.3 m

Gross profit Margin, %

33%35%36%35%

Sales and marketing expense

4 m

R&D expense

571.8 k

General and administrative expense

8.8 m

Operating expense total

16.2 m14.2 m13.8 m13.8 m

EBIT

(5.9 m)(2.2 m)(3.2 m)(3.5 m)

EBIT margin, %

(19%)(6%)(11%)(12%)

Interest expense

(230.6 k)(222.8 k)(219.7 k)(213.3 k)

Interest income

(230.6 k)(222.8 k)(219.7 k)

Pre tax profit

(6.1 m)(2.3 m)4.3 m(3.7 m)

Income tax expense

91 k8.2 k7.9 k1.1 k

Net Income

(6.2 m)(2.4 m)4.3 m(3.7 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

27.6 m22.1 m18 m16.2 m

Accounts Receivable

1.1 m

Inventories

7 m

Current Assets

37.9 m34.2 m30.8 m26.7 m

PP&E

10.9 m10.9 m11.5 m12.1 m

Total Assets

49.1 m45.4 m42.5 m38.8 m

Accounts Payable

5.1 m5.1 m5.7 m4.5 m

Dividends Payable

57.6 k57.6 k55.4 k55.1 k

Total Debt

430.4 k

Current Liabilities

16.6 m15.1 m8.1 m7.2 m

Total Liabilities

10.7 m

Preferred Stock

103.5 k98.5 k98.5 k98.5 k

Additional Paid-in Capital

59 m59.3 m58.3 m59.3 m

Retained Earnings

(30 m)(32.3 m)(28 m)(32 m)

Total Equity

28.9 m26.8 m31 m28.1 m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

1.7 x1.7 x1.4 x1.4 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(6.2 m)(2.4 m)4.3 m(3.7 m)

Depreciation and Amortization

1.3 m858.4 k872.9 k

Accounts Receivable

167.6 k624.7 k1.5 m

Inventories

(1.3 m)(1.6 m)(897 k)

Accounts Payable

7.9 k554.7 k(1.2 m)

Cash From Operating Activities

2.9 m(794.9 k)

Cash From Investing Activities

(282.3 k)(864.1 k)(1.9 m)

Dividends Paid

(230.4 k)(283.5 k)(220.8 k)

Cash From Financing Activities

(985.2 k)32.3 k896.1 k

Interest Paid

241.1 k219.7 k213.3 k

Income Taxes Paid

8 k3.7 k2 k
USDY, 2016

EV/EBIT

-6.2 x

EV/CFO

-27.2 x

Revenue/Employee

222.6 k

Financial Leverage

1.4 x

Retractable Technologies Market Value History

Retractable Technologies Company Life and Culture

You may also be interested in